Quotient Investors’s Bristol-Myers Squibb BMY Stock Holding History

Quotient Investors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,300	Closed	-$351K	–	152
2017 Q2	$351K	Sell	6,300 -900	-13%	-$49K	0.25%	107
2017 Q1	$392K	Sell	7,200 -200	-3%	-$11K	0.24%	124
2016 Q4	$432K	Buy	7,400 +1,200	+19%	+$65.6K	0.27%	114
2016 Q3	$334K	Buy	6,200 +900	+17%	+$57.8K	0.22%	140
2016 Q2	$390K	Sell	5,300 -1,850	-26%	-$131K	0.18%	146
2016 Q1	$457K	Buy	7,150 +1,050	+17%	+$66.2K	0.17%	145
2015 Q4	$420K	Buy	+6,100	New	+$403K	0.16%	138

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quotient Investors's BMY Position: Q3 2017 in Review

Quotient Investors sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 6,300 shares — an estimated $351K sold.

Quotient Investors first reported a position in BMY in Q4 2015 and held it in 7 quarters. The position peaked at $457K in Q1 2016. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

Quotient Investors reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
Quotient Investors sold 6,300 Bristol-Myers Squibb shares in Q3 2017, an estimated $351K.
Quotient Investors first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 7 quarters.
Quotient Investors's Bristol-Myers Squibb position peaked at $457K in Q1 2016.
1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.